 |
Articles: Research & Development |
Prior Articles
New, Long-Term Data for Odanacatib, Mercks Investigational Cat K Inhibitor, Showed Positive Results in Treating Osteoporosis
Merck & Co., 09/15/09
Free full text
Myriad Genetics Launches Public Awareness Campaign in Five Midwest States to Reach Women with Increased Risk of Hereditary Breast and Ovarian Cancer
Myriad, 09/15/09
Free full text
Strativa pharmaceuticals’ development partner, bioalliance pharma, presents phase iii study results of miconazole lauriad
Par Pharmaceutical, 09/15/09 Medtronic Study Shows Fluid Monitoring More Accurate Than Weight Measures for Heart Failure Patients
Medtronic, 09/15/09
Free full text
IMPROVE HF, A Guideline-Focused Performance Improvement Study, Demonstrates Significantly Improved Outpatient Heart Failure Quality of Care
Medtronic, 09/15/09
Free full text
ACR Creates LI-RADS Committee to Standardize Reporting for HCC
Imaging Economics, 09/15/09 Two new studies report increased survival rates in Tamiflu-treated patients with avian flu and severe seasonal flu
Roche, 09/14/09
Free full text
Laquinimod Immunomodulatory Action Confers Both Neuroprotective And Anti-Inflammatory Properties
Teva Pharmaceutical Industries, 09/14/09
Free full text
Financing of U.S. Biomedical Research and New Drug Approvals across Therapeutic Areas
PLoS ONE - Cardiovascular Disorders, 09/14/09 New data show patients with chronic low back pain maintained pain reduction on duloxetine
Boehringer Ingelheim, 09/14/09
Free full text
Encouraging phase II results with teriflunomide in patients with relapsing multiple sclerosis
Sanofi-aventis, 09/14/09
Free full text
Copaxone Significantly Reduced Disease Severity In Long-Term Treated Multiple Sclerosis Patients
Teva Pharmaceutical Industries, 09/14/09
Free full text
Data Show Medication Adherence is an Important Factor in the Treatment of Postmenopausal Osteoporosis
Amgen, 09/14/09
Free full text
Laquinimod immunomodulatory action confers both neuroprotective and anti-inflammatory properties
Active Biotech, 09/14/09
Free full text
Mercks ISENTRESS Tablets Studied in Comparison to Efavirenz in Combination Therapy Through 96 Weeks in HIV-1 Treatment-Naïve Patients
Merck & Co., 09/14/09
Free full text
Cytokinetics to Host a Research and Development Day on September
Cytokinetics, 09/14/09
Free full text
Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid
Amylin Pharmaceuticals, 09/11/09
Free full text
Comparison of Camelid Antibody Ligand to Protein A for Monoclonal Antibody Purification
BioPharm, 09/11/09
Free full text
Edie Falco and Cynthia Nixon Appear in New Stand Up To Cancer(TM) PSAs Designed to Educate Cancer Patients About the Importance Of Lowering One's Risk of Infection During Treatment
Amgen, 09/11/09
Free full text
VeriChip to Enter Security Field
HealthDataManagement, 09/11/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
